title: Cytokine secretion capacity of mononuclear cells in renal transplant recipients: the effect of two different dose schedules.
authors.affiliation: Clinic of Nephrology, University of Kiel, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Leimenstoll
authors.forename: R
authors.initials: R
authors.lastname: Engemann
authors.forename: J
authors.initials: J
authors.lastname: Gassel
authors.forename: S
authors.initials: S
authors.lastname: Hoffmann
authors.forename: D
authors.initials: D
authors.lastname: Preusse
authors.forename: H
authors.initials: H
authors.lastname: Schlag
authors.forename: W
authors.initials: W
authors.lastname: Niedermayer
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use; D016207:Cytokines / Q000097:blood*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007375:Interleukin-1 / Q000097:blood; D007376:Interleukin-2 / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D009000:Monocytes / Q000187:drug effects / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
chemical_list: D000911:Antibodies, Monoclonal; D016207:Cytokines; D007166:Immunosuppressive Agents; D007375:Interleukin-1; D007376:Interleukin-2; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D016572:Cyclosporine; C079843:inolimomab; D008775:Methylprednisolone